Allogeneic hematopoietic stem cell transplantation (HSCT) in first complete remission is a
standard of care for adult patients with Philadelphia chromosome (Ph)-negative acute …

Hematologic malignancies may require, at one point during their treatment, allogeneic bone
marrow transplantation. Total body irradiation combined with chemotherapy or radiomimetic …

AML is currently the first indication for allogeneic hematopoietic stem cell transplantation
(allo-HSCT), as shown by international transplant registries. The conditioning regimens are …

Total body irradiation (TBI), used as part of the conditioning regimen prior to allogeneic and
autologous hematopoietic cell transplantation, is the delivery of a relatively homogeneous …

Background Assessment of measurable residual disease (MRD) is rapidly transforming the
therapeutic and prognostic landscape of a wide range of hematological malignancies. Its …

HSCT is a therapeutic procedure that can cure and/or prolong life in a broad range of
hematologic disorders including malignant and nonmalignant pathologies. Conditioning is …

The impact of the conditioning intensity and TBI on acute GVHD (aGVHD) is still a matter of
debate. We analyzed 6848 adult recipients who received allogeneic hematopoietic cell …

Simple Summary We discussed the potential long-term toxicities associated with total body
irradiation, its current indications, and the technical advances in radiotherapy that have …

Total body irradiation (TBI) has been a pivotal component of the conditioning regimen for
allogeneic myeloablative haematopoietic stem cell transplantation (HSCT) in very-high-risk …

Background and purpose To reduce relapse risk, Total Body Irradiation (TBI) is part of
conditioning regimens for hematopoietic stem cell transplantation (HSCT) in pediatric acute …